BIRDIE BIOPHARMACEUTICALS INC has a total of 98 patent applications. It decreased the IP activity by 67.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are NELSON PETER JON, THERAPIX BIOSCIENCES LTD and GRUPO EMPRESARIAL DE PRODUCCIONES BIOFARMACEUTICAS Y QUIMICAS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 22 | |
#2 | Australia | 14 | |
#3 | EPO (European Patent Office) | 12 | |
#4 | WIPO (World Intellectual Property Organization) | 9 | |
#5 | Canada | 7 | |
#6 | China | 7 | |
#7 | Republic of Korea | 6 | |
#8 | Brazil | 5 | |
#9 | Mexico | 5 | |
#10 | Singapore | 5 | |
#11 | Taiwan | 4 | |
#12 | Japan | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Heterocyclic compounds | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Li Lixin | 84 |
#2 | Lixin Li | 10 |
#3 | Lau Walter | 9 |
#4 | Guan Huiping | 9 |
#5 | Yang Lihu | 3 |
#6 | Huiping Guan | 2 |
#7 | Liu Huatao | 1 |
#8 | Li Li-Xin | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020190690A1 | Immune modulatory compositions and methods for treating cancers | |
WO2020139618A1 | Immune modulatory combinations and methods for treating cancers | |
AU2019335366A1 | Imidazoquinoline compounds and uses thereof | |
CN110769827A | Pharmaceutical composition | |
CN108794467A | 2- amino-quinoline derivatives | |
AU2017205024A1 | Anti-Her2 combinations for treating tumors | |
MX2018008426A | Anti-egfr combinations for treating tumors. | |
BR112018013733A2 | anti-cd20 combinations for the treatment of tumors | |
CA2959564A1 | Anti-pd-l1 conjugates for treating tumors | |
TW201628651A | Anti-pd-l1 combinations for treating tumors | |
AU2015205753A1 | Compounds and compositions for treating HER2 positive tumors |